ND-322 HCl is a selective MT1-MMP/MMP2 inhibitor. MT1-MMP and MMP2 have been implicated as pro-tumorigenic and pro-metastatic factors in a wide variety of cancers including melanoma. ND-322 HCl reduces melanoma tumor growth and delays metastatic dissemination.
